1. Airaksinen O, Brox JI, Cedraschi C, Hildebrandt J, Klaber-Moffett J, Kovacs F, et al. Chapter 4.European guidelinesfor the management of chronic nonspecific low back pain. Eur Spine J. 2006;15(2):s192–300.
2. Andersson GB. Epidemiological features of chronic low-back pain. Lancet. 1999;354:585–91.
3. Freburger JK, Holmes GM, Agans RP, Jackman AM, Darter JD, Wallace AS, et al. The rising prevalence of chronic low back pain. Arch Intern Med. 2009;169(3):251–8.
4. Fatoye F, Gebrye T, Mbada CE, Useh U. Clinical and economic burden of low back pain in low- and middle-income countries: a systematic review. BMJ Open. 2023 Apr;13(4):e064119.
5. Juniper M, Le TK, Mladsi D. The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: A literature-based review. Expert Opin Pharmacother. 2009;10(16):2581–92.
6. Chou R, Huffman LH. Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med. 2007 Oct;147(7):492–504.
7. Marineo G. Untreatable pain resulting from abdominal cancer: new hope from biophysics? JOP. 2003 Jan;4(1):1–10.
8. Ricci M, Pirotti S, Scarpi E, Burgio M, Maltoni M, Sansoni E, et al. Managing chronic pain: Results from an open-label study using MC5-A Calmare® device. Support Care Cancer. 2012;20(2):405–12.
9. Starkweather AR, Coyne P, Lyon DE, Elswick RK, An K, Sturgill J. Decreased Low Back Pain Intensity and Differential Gene Expression Following Calmare®: Results From a Double-Blinded Randomized Sham-Controlled Study. Res Nurs Heal. 2015;38(1):29–38.
10. Ghatak RK, Nandi SN, Bhakta A, Mandal GC, Bandyopadhyay M, Kumar S. Prospective study of application of biological communication (cybernatics) in management of chronic low back pain--a preliminary report. Nepal Med Coll J. 2011;13(4):257–60.
11. Tantawy SA, Kamel DM, Abdelbasset WK, Nambi G. A randomized controlled trial investigating the impact of interferential therapy on pain, range of motion and quality of life in patients with chronic non-specific low back pain. Arch Balk Med :union:. 2020;55(1):47–54.
12. Yarnitsky D, Sprecher E, Zaslansky R, Hemli JA. Multiple session experimental pain measurement. Pain. 1996 Oct;67(2–3):327–33.
13. Vianin M. Psychometric properties and clinical usefulness of the Oswestry Disability Index. J Chiropr Med. 2008;7(4):161–3.
14. Malik K, Sahay P, Saha S, Kumar Das R, Mpt S, Professor A. Normative Values of Modified-Modified Schober Test in Measuring Lumbar Flexion and Extension: A Cross-Sectional Study. Int J Heal Sci Res. 2016;6(7):177.